vasoactive-intestinal-peptide and sodium-carbonate

1. The effect of hexamethonium on the exocrine pancreatic response to intraduodenal acidification and alkalinization, and the secretin and VIP release after these stimuli, was studied. 2. The hydroelectrolyte secretion after hydrochloric acid and sodium carbonate perfusion was reduced by hexamethonium treated (322 +/- 44% of maximum response in flow rate to sodium carbonate perfusion in untreated animals vs 140 +/- 12% in pretreated animals, and 252 +/- 19% of maximum response in flow rate to HCl in untreated animals vs 166 +/- 11% in pretreated animals). 3. However, hexamethonium has no effect on secretin plasma levels after either intraduodenal acidification or alkalinization. 4. On the contrary, the ganglion blocker significantly (P < 0.01) reduced plasma VIP levels in response to intraduodenal HCl (maximum response 320 +/- 74% in untreated vs 184 +/- 44% in hexamethonium-treated animals). 5. Plasma VIP levels showed a similar increase in both untreated (maximum response: 151 +/- 12%) and ganglion blocked animals (170 +/- 26%) in response to sodium carbonate. 6. These data suggest the existence of complex neural mechanisms in the exocrine pancreatic response to intraduodenal stimuli, these mechanisms being different depending on the intraduodenal stimulus.

Topics: Acids; Alkalies; Animals; Carbonates; Duodenum; Hexamethonium Compounds; Hydrochloric Acid; Intubation, Gastrointestinal; Male; Pancreas; Pancreatic Juice; Parasympathetic Nervous System; Rabbits; Receptors, Nicotinic; Secretin; Vasoactive Intestinal Peptide

Exocrine pancreatic response to duodenal perfusion with alkaline solutions (pH 11.4) was studied in the anaesthetized rabbit; secretin and vasoactive intestinal polypeptide (VIP) levels in portal plasma were measured and the contribution of cholinergic mechanisms was also evaluated. Intraduodenal perfusion of sodium carbonate stimulated flow rate and bicarbonate output to a maximum of 322 +/- 44 and 609 +/- 105% respectively compared with basal levels. Significant increases of plasma secretin levels, with a maximum of 267 +/- 38% as compared with basal, were also observed. A lower increase in VIP levels (maximum of 151 +/- 12%) was seen. All these effects, except the VIP response, were substantially inhibited by atropine. Our results show that exocrine pancreatic response to intraduodenal sodium carbonate is specifically focused on hydroelectrolytic secretion. Keeping in mind what occurs after intraduodenal alkaline phosphate buffer administration (at the same pH as sodium carbonate: 11.4) it seems that about 50% of the pancreatic response to sodium carbonate may be ascribed to pH and the remaining 50% to the carbonate anion. Moreover, this response would mainly be mediated by secretin, whose release can be facilitated by a cholinergic reflex.

Topics: Alkalies; Animals; Atropine; Carbonates; Duodenum; Hydrochloric Acid; Hydrogen-Ion Concentration; Injections; Male; Parasympathomimetics; Rabbits; Secretin; Solutions; Vasoactive Intestinal Peptide

The effect of various intraduodenal alkaline solutions (0.1 M NaHCO3, 0.1 M Na2CO3 and 0.025 M NaOH) on exocrine pancreatic secretion and the release of two peptides, secretin and vasoactive intestinal polypeptide, was studied in anesthetized rats. The flow rate of the pancreatic juice was stimulated up to a maximum of 179, 158 and 180% and the protein output up to 181, 131 and 162% (compared with basal) after duodenal perfusion of, respectively, 0.1 M NaHCO3, 0.1 M Na2CO3 and 0.025 M NaOH. Maximum increases in portal plasma secretin concentrations of 143, 146 and 190% and maximum increases in VIP of 116, 155 and 147% after, respectively, intraduodenal 0.1 M NaHCO3, 0.1 M Na2CO3, and 0.025 M NaOH were found. In conclusion duodenal alkalinization in the rat produces a pancreatic exocrine secretory response that may be partially ascribed to the effect of secretin and VIP.

Topics: Animals; Bicarbonates; Carbonates; Duodenum; Hydrogen-Ion Concentration; Male; Pancreas; Pancreatic Juice; Rats; Rats, Inbred Strains; Secretin; Sodium; Sodium Bicarbonate; Sodium Hydroxide; Vasoactive Intestinal Peptide